Given the lack of change in B cells and the significant increase in T cells in the TIL population in chemerin-expressing tumors, we then set out to define specific T cell subsets responsible for the chemerin-dependent anti-tumor effect. The gene discussed is RARRES2; the disease is neoplasm.